The Trump administration will soon begin accepting proposals for pilot programs to import prescription drugs from Canada, the Department of Health and Human Services announced Wednesday.
The new policy is the administration's latest move aimed at reducing sky-high drug prices. But it is likely to inflame long-standing tensions, as supporters of importation clash with those who fear it could threaten the integrity of America's pharmaceutical supply chain.
